Peroxynitrite is usually considered as a neurotoxic nitric oxidederivative. However, an increasing body of evidence suggests that, at low concentrations, peroxynitrite affords transient cytoprotection, both in vitro and in vivo. Here, we addressed the signaling mechanism responsible for this effect, and found that rat cortical neurons in primary culture acutely exposed to peroxynitrite (0.1 mmol/L) rapidly elicited Akt-Ser 473 phos- Peroxynitrite (PN), the product of the reaction between nitric oxide (NO) and superoxide (O 2
Peroxynitrite (PN), the product of the reaction between nitric oxide (NO) and superoxide (O 2
•) ) (Blough and Zafiriou 1985) , is spontaneously formed in mammalian cells under physiological conditions (Radi et al. 2001; Possel et al. 2002) . Initial work addressing the pathophysiology of PN yielded the widely accepted notion that this compound would be the long-term cytotoxic NO-derivative (Beckman et al. 1990; Radi et al. 1991) . Peroxynitrite involvement in cytotoxicity is documented by detecting protein 3-nitrotyrosination, i.e. the 'footprinting' like evidence for in situ PN formation (Ischiropoulos et al. 1992; Greenacre and Ischiropoulos 2001; Beal 2002) , associated with neurodegeneration and other disorders (Bolaños et al. 1997; Lipton 1999; Guix et al. 2005) . However, in apparent contradiction with this notion, it has been shown that contractile failure , arrhythmias (Altug et al. 1999) or necrosis (Nossuli et al. , 1998 provoked by ischemia-reperfusion in the rat heart in vivo can be abolished by infusion with PN. Moreover, we previously showed that pre-treatment of primary neurons in culture with PN exerts transient neuroprotection against acute oxidative stress (Garcia Nogales et al. 2003) .
These lines of evidence have raised the question of whether PN plays an active role in the etiology of neurodegenerative diseases, or its formation would be an emergency signal aimed at avoiding cellular death during oxidative insults (Ferdinandy and Schulz 2003; Bolaños et al. 2004) . In fact, PN rapidly stimulates, in neurons, the activity of glucose-6-phosphate dehydrogenase (Garcia Nogales et al. 2003) , the enzyme catalyzing the ratelimiting step of the pentose-phosphate pathway. Neurons can thus improve the capacity to regenerate glutathione (Garcia Nogales et al. 2003 ) -the antioxidant whose deficiency contributes to mitochondrial damage and apoptosis associated with certain neurodegenerative diseases (Bolaños et al. 1996; Jha et al. 2000; Diaz-Hernandez et al. 2005) . Whilst such an antioxidant defense mechanism renders neurons more resistant to early cellular oxidation, it remains unclear whether PN would stimulate long-lasting signaling pathway(s) aimed at avoiding the propagation of neurodegeneration.
Previous work performed in other laboratories using skin fibroblasts has reported that PN can cooperate or interfere with tyrosine kinase receptor-mediated signaling pathways (Klotz et al. 2002; Söylemez et al. 2003) . Peroxynitrite has been shown to oxidize -and thus inhibit -cysteinyl residue(s) of the protein tyrosine phosphatase (PTP) (Mallozzi et al. 1997; Takakura et al. 1999) , leading to inhibition of tyrosine kinase receptor dephosphorylation (Mallozzi et al. 1997; Klotz et al. 2002) . However, pre-treatment of skin fibroblast with PN, far from stimulating, attenuated PDGF-induced protein kinase B (Akt) phosphorylation (Klotz et al. 2000) . Thus, the results obtained so far appear rather confusing ), a fact that has prevented researchers from postulating a valid signaling mechanism that would be responsible for the neuroprotection afforded by PN.
Here, we aimed to investigate the involvement of the anti-apoptotic phosphoinositide-3-kinase (PI3K)/Akt signaling pathway in PN-mediated neuroprotection in rat cortical primary neurons. We demonstrate that PN affords neuroprotection by promoting Akt-Ser 473 phosphorylation. Furthermore, we show that this effect is due to inhibition -by oxidation -of 3-phosphoinositide 3-phosphatase with tensin homology (PTEN), but not to modification of Trk receptors. These results suggest that caution should be taken when considering PN scavengers as neuroprotectants, and highlight the potential benefits of PTEN interference against neurodegeneration.
Materials and methods

Reagents
Dulbecco's modified Eagle's medium (DMEM), poly-D-lysine, horse serum, cytosine arabinoside, ())epicatechin, etoposide, N-ethylmaleimide (NEM), hydrogen peroxide, glutathione ethyl ester (GSH), glutamate, and glycine were obtained from Sigma Chemical Co. (St Louis, MO, USA). DMEM was supplemented with penicillin (100 U/mL), streptomycin (100 lg/mL) and amphotericin B (0.25 lg/mL) (Sigma), except where indicated. Fetal bovine serum (FBS) was purchased from Roche Diagnostics (Heidelberg, Germany). Brain-derived neurotrophic factor (BDNF) was obtained from Peprotech EC (London, UK). Hybond Ò nitrocellulose membranes were from Amersham Biosciences (Buckinghamshire, UK). Plastic tissue culture dishes were purchased from Nunc (Roskilde, Denmark). Lipofectamine-2000 was purchased from Invitrogen (Groningen, The Netherlands). 2¢,7¢-Dichlorodihydrofluorescin diacetate (H 2 DCFDA) was obtained from Molecular Probes (Invitrogen). The PN donor 3-morpholinosydnonimine (SIN-1) was purchased from Alexis Corp. (San Diego, CA, USA). Other substrates, inhibitors, enzymes, and coenzymes were purchased from Sigma, Roche Diagnostics, Promega Biotech (Madrid, Spain), Pharmacia or Merck (Darmstadt, Germany).
Design of shRNAs for Akt1/2 Akt1/2 knockdown was achieved by RNA interference using a vector-based shRNA approach (Brummelkamp et al. 2002) . The shRNA-targeted cDNA sequence was chosen to knockdown Akt1 and Akt2 from either human and rat. The selected sequence was 5¢-GTGGTCATGTACGAGATGA-3¢ [corresponding to nt. 1207-1225 (NM_005163, human Akt1), 1215-1233 (NM_001626, human Akt2), 1051-1069 (NM_033230, rat Akt1) and 1293-1311 (NM_017093, rat Akt2)], which was designed according to a previously reported rational protocol (Reynolds et al. 2004 ) to accomplish criteria I, II, III, IV, VI, VII and VIII. As controls, we used either the firefly luciferase-targeted oligonucleotide 5¢-CTGACGCGGAATACTTCGA-3¢, as previously reported (Ohtsuka et al. 2004) or a scrambled Akt sequence (5¢-CGTTAC-ATCACGATCCTAC-3¢). All sequences were BLAST-confirmed for specificity. The forward and reverse synthetic 64-nt oligonucleotides (Isogen Life Technologies, Maarsen, The Netherlands) were designed, annealed, and inserted into the BglII/HindIII sites of the pSuper-neo/green fluorescent protein (GFP) vector, following the manufacturer's instructions (Oligoengine, Seatle, WA, USA). These constructions express 19 base-pair 9-nt stem-loop shRNAs targeted against human and rat Akt1/2 (Akt shRNA), luciferase (used as a shRNA control) or scrambled Akt (used as another shRNA control) mRNAs. The concomitant expression of GFP from this vector allowed the identification of transfected cells by flow cytometry.
Plasmid constructions
The cDNAs encoding wild type and mutated (Cys 124 fi Ser 124 ) PTEN were generous gifts from Prof. R. Pulido (Centro de Investigació n Príncipe Felipe, Valencia, Spain). Both cDNAs were subcloned into the corresponding EcoRI or BamHI sites of the pIRES2-EGFP mammalian expression vector (Invitrogen) and sequenced for confirmation. The concomitant expression of GFP from this vector allowed the identification of transfected cells by flow cytometry.
Neurons in primary culture
Cerebral cortex neurons in primary culture were prepared from fetal Wistar rats at 16 days of gestation . Dissociated cell suspensions were plated at a density of 2.5 · 10 5 cells/cm 2 in 60 cm 2 Petri dishes, or 6-or 12-wells plates, previously coated with poly-D-lysine (15 lg/mL) in DMEM supplemented with 10% fetal calf serum. Cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 /95% air. Forty-eight hours after plating, the medium was replaced with DMEM supplemented with 5% horse serum, 20 mmol/L D-glucose and cytosine arabinoside (10 lmol/L) to prevent non-neuronal proliferation. Neurons, which were approximately 99% Map2-positive, were transfected on day 4 (for Akt knockdown) or 6 (for PTEN expression).
HEK293T cells
Human embryonic kidney 293T (HEK293T) cells were maintained in DMEM supplemented with 10% (v/v) fetal calf serum. Cells were re-seeded at 10 5 cells/cm 2 1 day before transfections.
Synthesis of peroxynitrite
Peroxynitrite was synthesized and quantified spectrophotometrically (e 302 = 1670/M/cm) as previously described (Hughes and Nicklin 1968) . Alkaline stock solutions, with an approximate PN concentration of 0.5 mol/L, were stable at )70°C for at least 3-4 months.
Cell treatments
Cell transfections were performed with pSuper-neo/gfp-or pIRES2-EGFP-derived plasmid constructions using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions. After 6 h, the medium was removed and cells were further incubated for the indicated time periods in complete culture medium. Peroxynitrite was added to neurons in boli of 50, 100 or 500 lmol/L (final concentration) from 500-fold concentrated stock solutions in buffered Hanks' solution (5.26 mmol/L KCl, 0.43 mmol/L KH 2 H 2 PO 4 , 132.4 mmol/L NaCl, 4.09 mmol/L NaHCO 3 , 0.33 mmol/L Na 2 HPO 4 , 20 mmol/L glucose, 2 mmol/L CaCl 2 , and 20 mmol/L HEPES, final pH 7.4); the corresponding control incubations consisted of previously degraded (for 3 h at 37°C) PN solutions. Owing to the relative instability of authentic PN solutions at physiological pH, neurons were also incubated, for 15 min, in DMEM containing SIN-1, a PN source formed from nitric oxide and superoxide (Feelisch et al. 1989; Schrammel et al. 1998) . Preliminary experiments using a NO-sensitive electrode (ISO-NO) (not shown) suggested an approximate PN formation from SIN-1 (0.5 mmol/L) of about 10 lmol/L, as previously reported (Schrammel et al. 1998) . To ensure immediate maximum PN release from SIN-1, all SIN-1-containing solutions were always pre-incubated in DMEM at 37°C for 20 min before the addition to the cells. SIN-1 controls experiments were performed using a degraded SIN-1 solution (72 h at 37°C). To activate glutamate receptors thus promoting the endogenous formation of PN (Almeida and Bolaños 2001) , neurons were incubated, for 5 min, with 100 lmol/L glutamate (plus 10 lmol/L glycine) in buffered Hanks' solution (pH 7.4), either in the absence or in the presence of wortmannin (100 nmol/L), GSH (5 mmol/L) or superoxide dismutase (SOD) plus catalase (CAT) (100 U/mL each). Neurons were then washed and further incubated in culture medium for the indicated time period. To ensure a low degree of phosphorylation of Trk receptor and Akt in the controls, all experiments were carried out in neurons pre-incubated in serum-free DMEM for 6 h. Experiments combining PN and BDNF were performed as follows: neurons were incubated (in buffered Hanks' solution.) for 5 min with PN (100 lmol/L, or its degraded solution as control) followed by a further 5 min incubation in the absence or presence of BDNF (50 ng/mL); alternatively, neurons were incubated for 5 min in the absence or presence of BDNF (50 ng/mL) followed by a further 5 min incubation with PN (100 lmol/L or its degraded solution as control).
Western blotting
Cells were lysed for 20 min at 4°C in a buffer containing 1% nonidet NP-40, 5 mmol/L EDTA, 20 mmol/L Tris, pH 8.0, 137 mmol/L NaCl, 10% glycerol, 100 lmol/L phenylmethylsulfonyl fluoride, 50 lg/mL anti-papain, 50 lg/mL pepstatin, 50 lg/mL amastatin, 50 lg/mL leupeptine, 50 lg/mL bestatin, 1 mmol/L ovanadate, and 50 lg/mL soybean trypsin inhibitor. Extracts were centrifuged at 13 000 g for 20 min at 4°C and and aliquots containing 100 lg of protein from each sample, as determined extemporarily following the BCA TM Protein assay kit (Pierce, Rockford, IL, USA) using albumin as standard and the BenchMark TM pre-stained protein ladder (Invitrogen), and were subjected Rodrigo, Instituto Cajal, Madrid, Spain) antibodies. Anti-phosphofructokinase-1 (PFK1) was used as loading control . Anti-rabbit secondary antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Membranes were incubated with horseradish peroxidase-conjugated goat antirabbit IgG (1 : 10 000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and immediately incubated with Supersignal West Dura (Pierce) for 5 min before exposed to Kodak XAR-5 film (Sigma) for 1-3 min. Autoradiograms were scanned.
Identification of reduced and oxidized forms of PTEN by immunoblot analysis
This was performed following the method of Lee et al. (2002) . In brief, we followed identical protocol to that for western blotting, with the exceptions that the buffer contained 40 mmol/L NEM and, after centrifugation, aliquots were subjected to SDS-PAGE under reducing (715 mmol/L b-mercaptoethanol) or non-reducing (without b-mercaptoethanol) conditions.
Slot blotting
This was performed by vacuum-mediated transference of cellular protein extracts -obtained as indicated for western blotting -to nitrocellulose membranes, followed by immunoblotting against a-nitro-Tyr antibody, as indicated in the western blotting section.
Immunoprecipitation
Cells were lysed in a buffer containing 1% Nonidet NP-40, 137 mmol/L NaCl, 20 mmol/L Tris (pH 8.0), 10% glicerol, 5 mmol/ L EDTA, 1 mmol/L sodium orthovanadate, 1 mmol/L phenylmethylsulfonyl fluoride, 5 lg/mL leupeptin, 5 lg/mL aprotinin F. One milligram of protein was incubated with a-pan-Akt in the presence of 24 lL of protein A-sepharose during 4 h at 4°C. The inmunoprecipitated complex was extensively washed with the lysing buffer and the mixture was then subjected to SDS-PAGE.
Flow cytometric analysis of apoptotic cell death Allophycocyanin (APC)-conjugated annexin-V and 7-amino-actinomycin D (7-AAD) (Apoptosis Assay Kit; Becton Dickinson Biosciences, San José, CA, USA) were used to quantitatively determine the percentage of apoptotic cells by flow cytometry. Cells were stained with annexin V-APC and 7-AAD, following the manufacturer's instructions, and were analysed on a FACScalibur flow cytometer (15 mW argon ion laser tuned at 488 nm; CellQuest software, Becton Dickinson Biosciences). Both GFP + and GFP ) cells were analyzed separately, and the annexin V-APC-stained cells that were 7-AAD-negative were considered apoptotic . 
NADPH determination
Neurons were washed with ice-cold PBS and lysed in 0.5 mol/L KOH in 50% (vol/vol) ethanol. NADPH determination was performed exactly as previously described (Garcia Nogales et al. 2003) .
Immunofluorescence measurement of dichlorodihydrofluorescein (H 2 DCFDA) oxidation
Neurons were incubated with 10 lmol/L H 2 DCFDA in Hanks' solution (pH 7.4). After 30 min at 37°C, cells were washed twice with PBS and incubated with PN for 5 min in the presence of varying concentrations of epicatechin (10, 100 or 1000 lmol/L). Dichlorofluorescein fluorescence was measured in a Fluoroskan Ascent Fluorimeter (Thermo Electron Corporation, Milford, MA, USA; excitation at 485 nm, emission at 538 nm) and expressed in arbitrary units, as previously reported (Wang and Joseph 1999) .
Statistical analysis
Measurements from individual cultures were always performed in triplicate. The results are expressed as mean ± SEM values for three different culture preparations. Statistical analysis of the results was performed by one-way analysis of variance, followed by the least significant difference multiple range test. In all cases, p < 0.05 was considered significant.
Results
Peroxynitrite prevents etoposide-mediated apoptotic death by stimulating the PI3K/Akt pathway in primary cortical neurons In a previous study, we demonstrated that PN, applied either directly or released from the PN donor SIN-1, timedependently protected neurons against the apoptotic death caused by acute oxidative stress (Garcia Nogales et al. 2003) . Furthermore, we showed that protection was maximal at short-term periods (1-4 h), progressively disappearing thereafter (Garcia Nogales et al. 2003) . To explore the possibility that such protection could be a consequence of the activation of the anti-apoptotic pathway, phosphoinositide-3-kinase (PI3K)/Akt, we first investigated whether Akt was phosphorylated by PN treatment. As shown in Fig. 1a (upper panel), PN rapidly (5 min) triggered Akt phosphorylation at Ser 473 in a concentration-dependent manner, being evident at 100 lmol/L. To test whether Akt-Ser 473 phosphorylation was a consequence of PI3K activity, we used the PI3K inhibitor, wortmannin. As shown in Fig. 1a (lower panel), wortmannin (100 nmol/L) efficiently prevented AktSer 473 phosphorylation. Next, we confirmed the neuroprotective role of PN and showed that acute incubation of neurons with a bolus of PN at 100 lmol/L, i.e. the concentration shown to promote Akt-Ser 473 phosphorylation (Fig. 1a) protected them against the initiation of apoptotic death caused by etoposide (10 lg/mL; 1 h) (Fig. 1b) . Etoposide was used as the apoptotic death trigger, since this procedure has been previously validated to be suitable for the investigation of apoptotic death and neuroprotective pathways in cortical neurons (Nakajima et al. 1994) . Our results thus suggest that both phenomena -Akt phosphorylation and neuroprotection -might be linked. Blockade of PI3K activity with wortmannin fully abolished the protection that PN afforded against etoposide-mediated apoptotic death (Fig. 1b) . We further confirmed these results by determining the proportion of condensed or fragmented nuclei using DAPI staining (Figs 1c and d) . As shown in Fig. 1d , the increase in apoptotic death triggered by etoposide as assessed with DAPI was slightly higher than that using annexin V (Fig. 1b) , although PN afforded full protection (in the absence of wortmannin) regardless of the method used (Fig. 1d) . We next explored whether Akt phosphorylation could be linked to the increased NADPH concentrations by PN that we previously reported (Garcia Nogales et al. 2003) . We found that the increase in neuronal NADPH concentrations caused by PN was not impaired by wortmannin (in pmol/mg of protein, degraded PN, 52 ± 4; 100 lmol/L PN, 120 ± 11; degraded PN + wortmannin, 55 ± 6; 100 lmol/L PN + wortmannin, 121 ± 10; n = 3), ruling out the involvement of the PI3K/ Akt pathway in this effect.
We next designed a vector-based small hairpin RNA (shRNA) strategy against Akt to more specifically knockdown the PI3K/Akt pathway. As shown in Fig. 2a , expression of a plasmid vector carrying the shRNA Akt sequence efficiently reduced Akt protein in HEK293T cells 2 days after transfection. Control transfections were carried out expressing either a shRNA sequence against luciferase (shRNA Luc) (Diaz-Hernandez et al. 2005) or a corresponding scrambled Akt sequence. Transfection of neurons in primary culture with the shRNA Akt only resulted in a low degree of loss of neuronal survival when compared with the shRNA Luc or scrambled Akt transfections, at least at the time when the experiments were performed (3 days after transfection), although the values did not reach statistical differences (Fig. 2b) . Etoposide triggered a rapid (1 h) apoptotic response, whereas PN did not. Furthermore, PN prevented etoposide-mediated apoptotic death in neurons transfected with the shRNA Luc or scrambled Akt, but not in those transfected with shRNA Akt (Fig. 2b) . These results further support the essential role of Akt during PN neuroprotection. We next studied whether Akt silencing abolished neuroprotection by PN formed from SIN-1, a compound known to form PN by simultaneously releasing nitric oxide and superoxide. As shown in Fig. 2c , Akt-Ser 473 was phosphorylated 15 min after incubation with SIN-1, an effect that was prevented by wortmannin. Furthermore, SIN-1 prevented etoposide-mediated apoptotic death in neurons transfected with shRNA Luc, but not in those transfected with shRNA Akt (Fig. 2d) . Next, we incubated neurons with glutamate (100 lmol/L for 5 min), a treatment that we, and others, have shown to trigger spontaneous in situ PN formation (Almeida and Bolaños 2001; El-Remessy et al. 2003) . We found that glutamate rapidly (5 min) increased Akt-Ser 473 phosphorylation in primary neurons (Fig. 2e) , confirming a previous work (Sutton and Chandler 2002) . Furthermore, this effect was prevented with wortmannin ( Fig. 2e) incubation of neurons after glutamate treatment often causes neurotoxicity (excitotoxicity) (Dawson et al. 1991; Almeida and Bolaños 2001) . In contrast, acute glutamate treatment (100 lmol/L for 5 min) did not result in short-term (1 h after glutamate challenge) neurotoxicity (Fig. 2f) ; however, Akt silencing with shRNA enhanced apoptotic death (Fig. 2f) . These results confirm the involvement of the PI3K/Akt neuroprotective signaling pathway in the short-term incubation of cortical neurons with glutamate. To ascertain whether PN was involved in glutamate-mediated neuroprotection, GSH -a PN scavenger -or SOD/CAT -superoxide and H 2 O 2 scavengers -were used. The results (Fig. 2f) show that both treatments significantly prevented shRNA Akt-mediated apoptotic death in glutamate-treated neurons. In view of the difficulties to selectively scavenge PN without altering other potential oxidants within the cell, these results do not unambiguously determine the involvement of PN in glutamate-mediated short-term neuroprotection. However, these data clearly indicate that short-term glutamate treatment activates the PI3K/Akt pathway in primary cortical neurons, and that this activation is required for PN (and/or a related oxidant)-mediated neuroprotection.
The phosphorylation of Akt-Ser 473 promoted by peroxynitrite is not mediated through phosphorylation or nitration of Trk receptors in primary neurons Cortical neurons express the neurotrophin receptor TrkB, and are protected form apoptosis by its cognate ligand, BDNF (Hetman et al. 1999) . To try to understand the mechanism responsible for PN-mediated Ser 473 -Akt phosphorylation, we first focused on Trk receptors, since their activation -by phosphorylation -can stimulate the PI3K/Akt pathway. Cortical neurons were incubated with PN, alone, or in combination with BDNF. As shown in Fig. 3a , BDNF triggered the expected response by rapidly (10 min) promoting the phosphorylation of Trk receptors at Tyr 490 , hence confirming the expression of functional TrkB in these cells. In addition, PN treatment did not elicit Trk phosphorylation (Fig. 3a) . Moreover, pre-treatment of neurons with BDNF did not affect the response to PN; and, pre-treatment with PN did not affect the response to BDNF (Fig. 3a) . In view that PN was unable to alter Trk phosphorylation, we next studied whether it modified Trk receptor nitration, since such modification has been suggested to occur, at least in other cellular systems . Indeed, PN caused an increase in overall 3-nitrotyrosination of cell proteins (Fig. 3b, left panel) . To ascertain whether some of these proteins were Trk receptor(s), we performed immunoprecipitation using a pan-Trk antibody, and the precipitated proteins were subjected to western blotting with a nitro-tyrosine antibody. As shown in Fig. 3b (right panel) , PN did not cause Trk receptor nitration, as judged by the lack of 3-nitrotyrosinated proteins in Trk immunoprecipitates. We next showed that PN and BDNF-induced Akt phosphorylation were additive. As shown in Fig. 3c , PN increased the degree of Ser 473 -Akt phosphorylation caused by BDNF, and BDNF increased the degree of Ser 473 -Akt phosphorylation caused by PN. These results confirm that PN triggers Akt phosphorylation through a mechanism that does not involve Trk receptors in primary neurons, and suggest that PN and BDNF activate different signaling pathways that converge in Akt activation.
Protein oxidation, but not nitration, accounts for peroxynitrite-mediated neuroprotection and Akt phosphorylation Previous studies have demonstrated that PN can alter protein functions by nitrating or oxidizing critical Tyr or Cys residues, respectively . Accordingly, we next aimed to investigate whether the phosphorylation of Akt was consequence of either the nitrating or the oxidizing effect of PN in primary neurons. This was performed with using ())-epicatechin, an antioxidant compound known to differentially prevent nitration and oxidation by PN (Schroeder et al. 2001) . To validate the efficacy of this compound under our experimental conditions, we incubated neurons with PN in the presence of increasing concentrations of epicatechin. Then, we determined the oxidation of the fluorescent probe H 2 DCFA and the presence of nitrated proteins in the same cells. As shown in Fig. 4a , 100 lmol/L epicatechin prevented protein nitration (upper panel) without altering oxidation (lower panel) by PN; however, 1000 lmol/L epicatechin prevented both nitration and oxidation. Using an identical experimental protocol, we then investigated whether epicatechin was able to alter the neuroprotective effect of PN. As shown in Fig. 4b , PN prevented etoposide-mediated apoptotic death at 100 lmol/L, but not at 1000 lmol/L, epicatechin. In addition, we found that PN phosphorylated Akt-Ser 473 at 100 lmol/L, but not at 1000 lmol/L, epicatechin (Fig. 4c) . We also observed that epicatechin decreased Akt-Ser 473 phosphorylation in control (degraded PN-treated) neurons (Fig. 4c) , suggesting that epicatechin might directly affect the ability of Akt to be phosphorylated. To test this possibility, neurons were subjected to BDNF-mediated AktSer 473 phosphorylation in the presence of increasing concentrations of epicatechin. As depicted in Fig. 4d , epicatechin was unable to prevent BDNF-mediated AktSer 473 phosphorylation. Together, these results suggest that neuroprotection and Akt phosphorylation were due to the oxidizing, not nitrating, effect of PN.
Peroxynitrite oxidizes phosphoinositide phosphatase and prevents the excess apoptotic death caused by PTEN over-expression in primary neurons In view that Akt phosphorylation and neuroprotection exerted by PN were not due to the upstream activation of the Trk-PI3K/Akt pathway, we wondered whether those effects were related to the impairment of Akt dephosphorylation. Akt is an anti-apoptotic kinase that is activated by phosphorylation, promoted by phosphatidylinositol-dependent kinase 1 (PDK1), a kinase that is in turn activated by the effector phosphatidyl-inositol-3,4,5-trisphosphate (PIP 3 ), i.e. the product of PI3K activity. PTEN is the phosphatase that eliminates the 3-phosphate of PIP 3 , antagonizing PDK1-mediated Ser 473 -Akt phosphorylation. Conversely, PTEN inhibition, or mutation, impairs PIP 3 inactivation, thus enhancing the Akt-mediated anti-apoptotic pathway (Cully et al. 2006) . To address the possible role of PN on this PI3K-PTEN network, we first investigated whether PN altered the redox status of PTEN, a mechanism reported to regulate its activity (Kwon et al. 2004) . PTEN contains a critical Cys 124 residue that is essential for the correct protein folding and enzyme activity (Lee et al. 2002; Kwon et al. 2004 (Lee et al. 2002) (Figs 5a and b) , also triggered Akt phosphorylation in primary neurons. These results suggest that oxidation of PTEN by PN can account for the rapid increase of Akt-Ser 473 phosphorylation. Finally, we aimed to elucidate whether PTEN oxidation by PN was responsible for its neuroprotective properties. To accomplish this, we over-expressed the full-length PTEN cDNA (Fig. 5c ), or its inactive form carrying a Cys 124 fi Ser 124 mutation in cortical neurons. As shown in Fig. 5d , transfection of primary neurons with wild type PTEN spontaneously (after 18 h) elicited apoptotic death; however, transfection of neurons with the mutated form did not elicit apoptotic death when compared with neurons expressing the empty vector (pIRES) (Figs 5d and e) . Interestingly, incubation of neurons with PN or SIN-1 (5 or 15 min, respectively), Inhibition of PTEN activates PI3K/Akt neuroprotective signaling pathway 9 1 h before apoptotic death assessments, prevented the apoptotic death caused by over-expression of the wild type PTEN, but did not alter the response to expression of the mutated form (Figs 5d and e) .
Discussion
Here we show that incubation of primary cortical neurons in culture with PN -either authentic or formed from nitric oxide and superoxide -rapidly triggers phosphorylation of Akt at Ser 473 and protects neurons against the apoptotic death caused by etoposide. Such effects were abolished by inhibition of PI3K activity with wortmannin, or by Akt shRNA knock down, suggesting that PI3K/Akt pathway mediated the anti-apoptotic effect of PN. Moreover, glutamate receptor stimulation, in conditions known to elicit PN formation (32, 39), caused Akt-Ser 473 phosphorylation; conversely, shRNA-mediated Akt knockdown promoted apoptotic death. Together, these results strongly suggest that PN can act as a signaling molecule capable of activating the anti-apoptotic PI3K/Akt pathway in neurons.
In principle, our results might be similar to those obtained by other laboratories, which reported that PN promoted AktSer 473 phosphorylation in human skin fibroblasts (Klotz et al. 2000) . However, the latter study did not contemplate the potential cell death/survival relevance of these findings, and the mechanism suggested for Akt-Ser 473 phosphorylation is different from the one we found. Thus, we demonstrate that PN promoted Akt-Ser 473 phosphorylation without altering the phosphorylation status of TrkB, an endogenous anti-apoptotic tyrosine kinase receptor for cortical neurons (Hetman et al. 1999) . In other cellular systems, it has been reported that PN oxidized protein-tyrosine-phosphatases (PTP) leading to the inhibition of receptor tyrosine kinase dephosphorylation (Mallozzi et al. 1997; Takakura et al. 1999; Klotz et al. 2002) . In addition, it has been suggested that pre-treatment of human skin fibroblasts with PN impairs subsequent PDGFinduced phosphorylation of its cognate tyrosine kinase receptor (Klotz et al. 2000) . In contrast, we show that PN and the endogenous TrkB ligand, BDNF, enhance, in an additive fashion, Akt-Ser 473 phosphorylation. This is consistent with the notion that PN and BDNF act on different pathways converging in PI3K/Akt activation, in cortical neurons.
Here we show that both, PN-mediated Akt-Ser 473 phosphorylation and anti-apoptotic effects were due to its oxidizing potential, and that these phenomena were closely associated with PTEN oxidation. This raises the possibility that our findings could also be attributable to other oxidizing species formed during PN degradation (e.g. hydroxyl radical), or formation from SIN-1 or glutamate (e.g. superoxide). Besides this, over-expression of the wild type PTEN in primary neurons significantly increased apoptotic death when compared with the expression of the inactive, Cys 124 fi Ser 124 mutated form, confirming the importance of Cys 124 residue for PTEN full activity (Lee et al. 2002; Kwon et al. 2004) . Moreover, we show that incubation of wild type PTEN-transfected neurons with PN prevented the excess PTEN-induced apoptotic death. Together, these results indicate that PN -and/or any of its related oxidizing species -oxidizes PTEN, possibly at Cys 124 , hence impairing PTEN to fold properly to acquire its full activity (Lee et al. 2002) . Interestingly, inhibition of the pro-apoptotic function of PTEN by genetic mutations is known to increase proliferation and the probability of tumorigenesis in certain cycling cells (Lee et al. 2002; Cully et al. 2006) . However, the neurons used in this study are post-mitotic , making it unlikely that PTEN inhibition by PN could cause increased proliferation. Rather, the anti-apoptotic effect caused by PN-mediated inhibition of PTEN would likely be associated with neuroprotection.
The notion that PN would exert neuroprotection is not in disagreement with the results of other groups (Keynes et al. 2004 ) that have reported the high resistance of neurons against glutamate. We provide a mechanistic explanation for this phenomenon based on the activation of the PI3K/Akt pathway, since Akt knockdown enhanced neuronal vulnerability to glutamate. We are aware that the neuroprotective role that we herein propose for PN argues against the widely held notion that it would be the neurotoxic NOderivative (Dawson et al. 1991) . Relatively high concentrations of PN acutely applied to cell cultures and mitochondrial preparations cause oxidation and/or nitration of the complexes of the mitochondrial respiratory chain (Bolaños et al. 1995) , presumably leading to a loss of function and neurodegeneration. Moreover, it has been recently reported that PN (0.5 mmol/L)-induced apoptosis of PC12 cells was associated with dephosphorylationleading to inactivation -of Akt (Shacka et al. 2006) , a result that might be in contradiction with our work. However, it should be mentioned that Akt phosphorylation was assessed, in such study, 16 h after PN additions (Shacka et al. 2006) . In contrast, we examined Akt phosphorylation 5 min after PN exposure, and neuronal viability within 1 h, a fact that might explain the discrepancy. On the other hand, 3-nitrotyrosine immunostaining has been found in human post-mortem brain sections of patients that suffered from neurodegenerative diseases, such as Alzheimer's disease, suggesting PN formation (Bolaños et al. 1997; Sultana et al. 2006) . However, it has been questioned whether oxidative -and nitrosative-stress is cause, or consequence, of neurodegeneration (Andersen 2004) . In view of these considerations and, in light of our findings, it is tempting to suggest that PN formation would represent an early anti-apoptotic cell response aimed at avoiding the propagation of neurodegeneration. Furthermore, our results support the recently highlighted notion (Zhu et al. 2006 ) that PTEN may be a molecular target for interfering with neurodegenerative diseases.
